Evaluating flow measurement and ultrasound imaging in vein bypass surgery for limb ischemia
Official title: Open, Prospective, Multicentre Study Addressing the Immediate Benefits and the Prognostic Value of Intraoperative Completion Control Following Infrainguinal Bypass Surgery in Chronic Limb-Threatening Ischemia (CLTI) Patients
Run by Medistim ASA · NCT06264843 · Data updated 2026-11-12
This study is testing if using special tools to measure blood flow and take pictures of veins can help improve the results of vein bypass surgery for people with serious circulation problems in their legs.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 450 (estimated) |
| Sponsor | Medistim ASA Industry-sponsored |
| Locations | 1 site (San Francisco, California) |
| Status | Recruiting |
| Started | November 14, 2024 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | October 14, 2025 |
| Trial ID | NCT06264843 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals diagnosed with chronic limb-threatening ischemia due to atherosclerotic infra-popliteal peripheral artery disease who have suitable vein conduits for bypass.
✕Probably not a fit
Patients with non-atherosclerotic lesions or those requiring bypass with artificial conduits will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to identify and validate the effectiveness of flow measurement and ultrasound imaging techniques in patients undergoing vein bypass surgery for chronic limb-threatening ischemia. The study will utilize MiraQ with Transit-Time Flow Measurement (TTFM) and L15 High Frequency Ultrasound (HFUS) probes to assess blood flow and vascular health. Participants will be monitored to gather data on the outcomes of their surgeries and the accuracy of these imaging methods.
Why it matters
Potential benefit: If successful, this study could enhance surgical outcomes and improve the management of patients with chronic limb-threatening ischemia.
How similar studies have gone: While this approach is innovative, similar studies have shown promise in improving surgical techniques and patient outcomes in vascular surgery.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Chronic Limb-Threatening Ischemia as defined by presence of Peripheral Artery Disease (PAD) in combination with rest pain, gangrene, or a lower limb ulceration\>2 weeks duration (ref Global Guidelines) * Atherosclerotic infra-popliteal PAD * Adequate distal anastomotic target (crural, tibial or popliteal below the knee with one single run-off) between knee and ankle distal to the stenotic/occluded segment. * Available autogenous vein conduit based on preoperative vein mapping. * Understand the nature of the procedure and willingness to comply with protocol. Attend follow-up appointments and provide written informed consent. Exclusion Criteria: * Bypass with artificial conduit or cryopreserved allografts * Bypass for non-atherosclerotic lesions * Life-expectancy less than 2 years * Any psychological, developmental, physical or emotional disorder that the investigator believes would interfere with surgery or follow-up. * Any condition that the investigator believes should exclude participation. * Excessive risk for adverse events during open surgery as judged by the investigator.
Where it's running
-
University of California
San Francisco, California, United States Recruiting
Study contacts
- Study coordinator: Anne Waaler
- Email: anne.waaler@medistim.com
- Phone: +4790892713
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Esprit BTK everolimus-eluting resorbable scaffold in infrapopliteal artery disease for CLTI
This study tests whether the Esprit BTK Everolimus Eluting Resorbable Scaffold works in real-world patients with chronic limb-threatening ischemia and heavily calcified infrapopliteal arteries.
-
Orbital Atherectomy to Prep Calcified Leg Arteries in CLTI Patients
This Europe-wide study tests how well orbital atherectomy helps patients with chronic limb-threatening ischemia when opening heavily calcified leg arteries.
-
Predictors of Major Adverse Limb Events After Iliac Artery Stenting
This study tests what factors predict serious limb-related problems after iliac artery stenting in adults with peripheral artery disease.
-
Colchicine for people with severe limb-threatening leg artery disease
A low-dose colchicine pill is being tested to see if it can help people with chronic limb-threatening ischemia avoid worsening of their leg condition and improve outcomes.
-
Imaging plaque activity across the body in people with symptomatic peripheral arterial disease
This project will use whole-body PET-CT and CT angiography with several tracers to see if imaging can detect inflammation, microcalcification, and clot activity in people with symptomatic peripheral arterial disease.
-
Vessel recoil after below-the-knee revascularization in high-risk CLTI patients
This study tests how much vessels recoil after a final endovascular treatment in adults with chronic limb-threatening ischemia affecting below-the-knee arteries.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.